col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


43 Results       Page 1

 [1] 
Springer-Verlag: Stem Cell Reviews and Reports
  original article Date Title Authors   All Authors
1 [GO] 2026―May―11 Bone Marrow Mesenchymal Stem Cell Extracellular Vesicle Treatment of Respiratory Failure from COVID-19: Endpoint Analysis of Expanded Access Safety Trial Vikram Sengupta, Sascha Qian, John T. Ransom, Sam Suzuki, David J. Park, Timothy I. Melson, et al. (+5)
2 [GO] 2024―Sep―28 Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19 Iago Carvalho Schultz, Ana Claudia dos Santos Pereira Andrade, Isabelle Dubuc, Audrée Laroche, Isabelle Allaeys, Etienne Doré, et al. (+6)
3 [GO] 2024―May―09 The Onset of Intussusceptive Angiogenesis in COVID-19 Patients Might Come from the Mobilization of Stem Cell Sub-Populations Expressing the Hemangioblast Marker CD143 Lou Soret, Coralie L. Guerin, Guillaume Goudot, Léa Guyonnet, Jean-Luc Diehl, Aurélien Philippe, et al. (+2)
4 [GO] 2024―Mar―01 Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Jinlv Qin, Guizuo Wang, Dong Han
5 [GO] 2023―Dec―01 CD147 Plasma Levels in Hospitalised Patients with Covid-19 Pneumonia Predict Illness Severity and In-Hospital Mortality David M. Smadja, Aurélien Philippe, Eloara V. M. Ferreira, Rudolf K. F. Oliveira, Colm McCabe, Lan Zhao
6 [GO] 2022―Nov―24 How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? Stéphanie Pons, Fabrice Uhel, Eric Frapy, Youssouf Sérémé, Lara Zafrani, Hugues Aschard, David Skurnik
7 [GO] 2022―Aug―18 Increased Circulating CD62E+ Endothelial Extracellular Vesicles Predict Severity and in- Hospital Mortality of COVID-19 Patients Fariza Mezine, Coralie L. Guerin, Aurélien Philippe, Nicolas Gendron, Lou Soret, Olivier Sanchez, et al. (+5)
8 [GO] 2022―Jul―07 MSC-Exosomes Carrying miRNA - Could they Enhance Tocilizumab Activity in Neuropathology of COVID-19? Iago C. Schultz, Ana Paula S. Bertoni, Márcia Rosângela Wink
9 [GO] 2022―Jun―04 Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia Meiping Chu, Hao Wang, Linjie Bian, Jiehui Huang, Danping Wu, Ruiting Zhang, et al. (+3)
10 [GO] 2022―Feb―19 SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism Romy Kronstein-Wiedemann, Marlena Stadtmüller, Sofia Traikov, Mandy Georgi, Madeleine Teichert, Hesham Yosef, et al. (+6)
11 [GO] 2021―Oct―22 Correction to: Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System Kyle Ernzen, Aaron J. Trask, Mark E. Peeples, Vidu Garg, Ming-Tao Zhao
12 [GO] 2021―Aug―08 Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System Kyle Ernzen, Aaron J. Trask, Mark E. Peeples, Vidu Garg, Ming-Tao Zhao
13 [GO] 2021―Jul―28 Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey Nesrin O. Ercelen, Kubra Cigdem Pekkoc-Uyanik, Nagihan Alpaydin, Gokay Rasit Gulay, Murat Simsek
14 [GO] 2021―Jun―28 Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology? Milad Zandi, Emad Behboudi, Saber Soltani
15 [GO] 2021―Apr―13 Targeting the PANoptosome with miRNA Loaded Mesenchymal Stem Cell Derived Extracellular Vesicles; a New Path to Fight Against the Covid-19? Zafer Çetin
16 [GO] 2021―Feb―11 Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19 V. Kh. Khavinson, B. I. Kuznik, S. V. Trofimova, V. A. Volchkov, S. A. Rukavishnikova, O. N. Titova, et al. (+4)
17 [GO] 2021―Feb―11 P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation Lyvia Lintzmaier Petiz, Talita Glaser, Julio Scharfstein, Mariusz Z. Ratajczak, Henning Ulrich
18 [GO] 2021―Jan―28 Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment Arefeh Basiri, Fatemeh Mansouri, Arezo Azari, Parviz Ranjbarvan, Fateme Zarein, Arash Heidari, Ali Golchin
19 [GO] 2021―Jan―28 Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink
20 [GO] 2021―Jan―12 Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs Elham Jamshidi, Amirhesam Babajani, Pegah Soltani, Hassan Niknejad
21 [GO] 2021―Jan―07 Dimethyl Fumarate Can Enhance the Potential Therapeutic Effects of Epidermal Neural Crest Stem Cells in COVID-19 Patients Anahid Safari, Zahra Khodabandeh, Afshin Borhani-Haghighi
22 [GO] 2021―Jan―05 Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient Tali-Anne Szwebel, David Veyer, Nicolas Robillard, Deborah Eshagh, Etienne Canoui, Thomas Bruneau, et al. (+14)
23 [GO] 2021―Jan―05 Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body? Hesam Saghaei Bagheri, Mohammad Karimipour, Morteza Heidarzadeh, Hadi Rajabi, Emel Sokullu, Reza Rahbarghazi
24 [GO] 2021―Jan―05 Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible? Irma Virant-Klun, Franc Strle
25 [GO] 2020―Nov―07 Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19 Drashti Desai, Pravin Shende
26 [GO] 2020―Oct―21 Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein James Ropa, Scott Cooper, Maegan L. Capitano, Wouter Van’t Hof, Hal E. Broxmeyer
27 [GO] 2020―Oct―07 An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner Himanshu Agrawal, Neeladrisingha Das, Sandip Nathani, Sarama Saha, Surendra Saini, Sham S. Kakar, Partha Roy
28 [GO] 2020―Oct―03 Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility Ali Golchin
29 [GO] 2020―Sep―12 COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy Yogesh Kumar Verma, Ranjan Verma, Nishant Tyagi, Amanpreet Behl, Subodh Kumar, Gurudutta U. Gangenahalli
30 [GO] 2020―Sep―07 Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19 José Lucas Martins Rocha, Waldir César Ferreira de Oliveira, Nádia Cássia Noronha, Natalia Cristine Dias dos Santos, Dimas Tadeu Covas, Virgínia Picanço-Castro, et al. (+2)
31 [GO] 2020―Aug―22 Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19 Fernanda Majolo, Guilherme Liberato da Silva, Lucas Vieira, Luís Fernando Saraiva Macedo Timmers, Stefan Laufer, Márcia Inês Goettert
32 [GO] 2020―Aug―19 Epidermal Neural Crest Stem Cells as a Perspective for COVID-19 Treatment Mohammad Saied Salehi, Sareh Pandamooz, Benjamin Jurek
33 [GO] 2020―Aug―13 Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics You Jeong Park, Jeffrey Farooq, Justin Cho, Nadia Sadanandan, Blaise Cozene, Bella Gonzales-Portillo, et al. (+8)
34 [GO] 2020―Aug―03 Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension Sarama Saha, Sasanka Chakrabarti, Praveen Kumar Singh, Jit Poddar, Soumitra Satapathi, Surendra Saini, et al. (+2)
35 [GO] 2020―Aug―01 Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients Diana Esquivel, Rangnath Mishra, Prabhat Soni, Rajasekar Seetharaman, Anjum Mahmood, Anand Srivastava
36 [GO] 2020―Jul―21 Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy Ekaterine Berishvili, Laurent Kaiser, Marie Cohen, Thierry Berney, Hanne Scholz, Yngvar Floisand, Jonas Mattsson
37 [GO] 2020―Jul―20 SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome Mariusz Z. Ratajczak, Kamila Bujko, Andrzej Ciechanowicz, Kasia Sielatycka, Monika Cymer, Wojciech Marlicz, Magda Kucia
38 [GO] 2020―Jul―13 Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19 Suchi Gupta, Vishnu Krishnakumar, Yashvi Sharma, Amit Kumar Dinda, Sujata Mohanty
39 [GO] 2020―Jun―20 Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises Arefeh Basiri, Zahra Pazhouhnia, Nima Beheshtizadeh, Mahdieh Hoseinpour, Amene Saghazadeh, Nima Rezaei
40 [GO] 2020―Jun―04 Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage Bipasha Bose
41 [GO] 2020―May―12 Is COVID-19 a New Hematologic Disease? Benjamin Debuc, David M. Smadja
42 [GO] 2020―Apr―20 CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement Henning Ulrich, Micheli M. Pillat
43 [GO] 2020―Apr―13 Mesenchymal Stem Cell Therapy for COVID-19: Present or Future Ali Golchin, Ehsan Seyedjafari, Abdolreza Ardeshirylajimi
 [1] 

43 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec